1. Home
  2. MTCH vs TECH Comparison

MTCH vs TECH Comparison

Compare MTCH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Match Group Inc.

MTCH

Match Group Inc.

HOLD

Current Price

$32.59

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.50

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTCH
TECH
Founded
1986
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
9.5B
IPO Year
2015
1989

Fundamental Metrics

Financial Performance
Metric
MTCH
TECH
Price
$32.59
$58.50
Analyst Decision
Hold
Strong Buy
Analyst Count
15
14
Target Price
$35.00
$71.23
AVG Volume (30 Days)
3.0M
1.8M
Earning Date
02-03-2026
02-04-2026
Dividend Yield
2.29%
0.55%
EPS Growth
N/A
N/A
EPS
2.15
0.49
Revenue
$3,469,367,000.00
$1,216,732,000.00
Revenue This Year
$2.06
$2.33
Revenue Next Year
$3.46
$7.05
P/E Ratio
$15.46
$120.21
Revenue Growth
N/A
3.85
52 Week Low
$26.39
$46.01
52 Week High
$39.20
$79.28

Technical Indicators

Market Signals
Indicator
MTCH
TECH
Relative Strength Index (RSI) 43.26 42.18
Support Level $33.35 $58.75
Resistance Level $34.35 $61.20
Average True Range (ATR) 0.75 2.01
MACD -0.05 -0.54
Stochastic Oscillator 4.24 13.44

Price Performance

Historical Comparison
MTCH
TECH

About MTCH Match Group Inc.

Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: